Table 1. AGREE II parameters.

Domain	Item	Description
1 Scope and purpose	1	The overall objective(s) of the guideline is (are) specifically described
	2	The health question(s) covered by the guideline is specifically described
	3	The population to whom the guideline is meant to apply is specifically described
2 Stakeholder involvement	4	The guideline development group includes individuals from all relevant professional groups
	5	The views and preferences of the target population (patients, public, etc.) have been sought
	6	The target users of the guideline are clearly defined
3 Rigor of development	7	Systematic methods were used to search for evidence
	8	The criteria for selecting the evidence are clearly described
	9	The strengths and limitations of the body of evidence are clearly described
	10	The methods for formulating the recommendations are clearly described
	11	The health benefits, side effects, and risks have been considered in formulating the recommendations
	12	There is an explicit link between the recommendations and the supporting evidence
	13	The guideline has been externally reviewed by experts prior to its publication
	14	A procedure for updating the guideline is provided
4 Clarity of presentation	15	The recommendations are specific and unambiguous
	16	The different options for management of the condition or health issue are clearly presented
	17	Key recommendations are easily identifiable
5 Applicability	18	The guideline describes facilitators and barriers to its application
	19	The guideline provides advice and/or tools on how the recommendations can be put into practice
	20	The potential resource implications of applying the recommendations have been considered
	21	The guideline presents monitoring and/or auditing criteria
6 Editorial independence	22	The views of the funding body have not influenced the content of the guideline
	23	Competing interests of guideline development group members have been recorded and addressed